These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11835208)

  • 21. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
    Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
    Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control.
    Xu T; Nahar K; Dave R; Bates S; Morris K
    Pharm Res; 2018 May; 35(7):140. PubMed ID: 29748722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface crystallization of indomethacin below Tg.
    Wu T; Yu L
    Pharm Res; 2006 Oct; 23(10):2350-5. PubMed ID: 16927184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin.
    Bhugra C; Shmeis R; Pikal MJ
    J Pharm Sci; 2008 Oct; 97(10):4446-58. PubMed ID: 18228583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
    Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
    Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
    Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
    Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.
    Burnett DJ; Khoo J; Naderi M; Heng JY; Wang GD; Thielmann F
    AAPS PharmSciTech; 2012 Dec; 13(4):1511-7. PubMed ID: 23135965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase characterization of indomethacin in adsorbates onto hydroxyethylcellulose.
    Bogdanova S; Bontcheva E; Avramova N
    Drug Dev Ind Pharm; 2007 Aug; 33(8):900-6. PubMed ID: 17729108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement.
    Otsuka M; Nakahigashi Y; Matsuda Y; Kokubo T; Yoshihara S; Fujita H; Nakamura T
    Biomed Mater Eng; 1997; 7(5):291-302. PubMed ID: 9457380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural evolution of indomethacin particles upon milling: time-resolved quantification and localization of disordered structure studied by IGC and DSC.
    Planinsek O; Zadnik J; Kunaver M; Srcic S; Godec A
    J Pharm Sci; 2010 Apr; 99(4):1968-81. PubMed ID: 20049752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of melt-quenched and milled amorphous solids of gatifloxacin.
    Hattori Y; Suzuki A; Otsuka M
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1851-6. PubMed ID: 27109418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.